167 related articles for article (PubMed ID: 30392891)
1. Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
Li C; Song B; Santos PM; Butterfield LH
Cell Immunol; 2019 Jan; 335():59-67. PubMed ID: 30392891
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells.
Pardee AD; Shi J; Butterfield LH
J Immunol; 2014 Dec; 193(11):5723-32. PubMed ID: 25355916
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death.
Vujanovic L; Stahl EC; Pardee AD; Geller DA; Tsung A; Watkins SC; Gibson GA; Storkus WJ; Butterfield LH
Cancer Immunol Res; 2017 Jun; 5(6):493-502. PubMed ID: 28468916
[TBL] [Abstract][Full Text] [Related]
5. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
[TBL] [Abstract][Full Text] [Related]
7. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
9. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer.
Liu Y; Daley S; Evdokimova VN; Zdobinski DD; Potter DM; Butterfield LH
J Immunol; 2006 Jul; 177(1):712-21. PubMed ID: 16785570
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory impact of α-fetoprotein.
Munson PV; Adamik J; Butterfield LH
Trends Immunol; 2022 Jun; 43(6):438-448. PubMed ID: 35550875
[TBL] [Abstract][Full Text] [Related]
11. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M
Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090
[TBL] [Abstract][Full Text] [Related]
12. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
Front Immunol; 2019; 10():1264. PubMed ID: 31214199
[TBL] [Abstract][Full Text] [Related]
13. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC
Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271
[TBL] [Abstract][Full Text] [Related]
14. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
East JE; Sun W; Webb TJ
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
[TBL] [Abstract][Full Text] [Related]
15. Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.
Liu Y; Butterfield LH; Fu X; Song Z; Zhang X; Lu C; Ding G; Wu M
Int J Oncol; 2011 Jul; 39(1):245-53. PubMed ID: 21491085
[TBL] [Abstract][Full Text] [Related]
16. Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.
Rzemieniak SE; Hirschfeld AF; Victor RE; Chilvers MA; Zheng D; van den Elzen P; Turvey SE
Immunology; 2010 Jun; 130(2):288-95. PubMed ID: 20102408
[TBL] [Abstract][Full Text] [Related]
17. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.
Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H
PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738
[TBL] [Abstract][Full Text] [Related]
18. α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells.
Yamamoto M; Tatsumi T; Miyagi T; Tsunematsu H; Aketa H; Hosui A; Kanto T; Hiramatsu N; Hayashi N; Takehara T
Clin Exp Immunol; 2011 Aug; 165(2):211-9. PubMed ID: 21592114
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.
Lameris R; Schneiders FL; de Gruijl TD; van der Vliet HJ
Methods Mol Biol; 2014; 1139():155-65. PubMed ID: 24619678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]